Navigation Links
Allergy-Induced Asthma More Common in Affluent Countries
Date:9/17/2007

g conditions from rural areas in Africa to urban areas of Europe.

Parents filled out questionnaires, and allergy tests via skin testing were completed on almost 32,000 youngsters. Another 8,951 children also had blood tests to measure levels of a substance known as IgE that increases in response to allergens.

Overall, children with allergies who lived in non-affluent countries were 2.2 times more likely than their non-allergic counterparts to have asthma. But, youngsters with allergies from wealthier, more developed nations were four times more likely to have asthma than their non-allergic peers.

The areas with the highest levels of allergy-induced asthma were Guangzhou, China (93.8 percent); Hong Kong, China (59.6 percent); and the Netherlands (58.6 percent). The areas with the lowest rates of allergic asthma were Ankara, Turkey (0 percent) and Mumbai, India (2 percent).

"The gist of this study is that, in more affluent countries, asthma seems more related to allergy than to other triggers," said Dr. Alan Khadavi, a pediatric asthma specialist at New York University Medical Center in New York City. "This study seems to support the hygiene hypothesis, because normal gut flora can be altered in affluent countries, with the use of antibiotics and living very cleanly."

However, just because the levels of allergic asthma are higher in more developed nations doesn't mean poorer countries escape the airway disease. For example, in Ankara, Turkey, where there was no incidence of allergic asthma, nearly 11 percent of children reported wheezing during the previous year. Yet, in Guangzhou, China -- the area with a nearly 94 percent rate of allergic asthma -- just 3.2 percent of the children in the study had experienced wheezing during the past year.

"Asthma is a complex disease caused by many different things, and it can present with many different symptoms," said Dr. Sandra Braganza, a pediatric asthma spec
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New Drug for Bronchial Asthma
2. Asthma may actually be prevented by Dust and Dirt
3. Inhaled Steroids Safe & Effective for Children with Asthma
4. What happens when Asthmatics consume Aspirin?
5. Fireworks can spell death for asthmatic children
6. New vaccine helps allergy and asthma patients
7. New vaccine helps allergy and asthma patients
8. Nearly all asthma deaths preventable
9. Asthma! A new warning for heart disease
10. Soluble IL-4 Receptor - A new boon for asthmatics
11. Cats to protect children from asthma
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Americans United for Life Condemns Ruling Increasing Minors' Access to Dangerous Plan B 2Health News:AANS President to Testify on Patient Access to Care 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 3Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 4Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 5Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 6Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 7Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 8Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 9Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 10Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 11Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 12Health News:Young Survival Coalition and Living Beyond Breast Cancer Announce Support for Rep. Wasserman Schultz's 'The Early Act' 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 3
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 1Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 2Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 3Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 1Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 2Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 3SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 1SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 2SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 3